Graphiti – fast (<1h) phenotypic AST
Bringing fast (1h) phenotypic AST using patented graphene sensing technology
Save time and lives. Perform fast and highly parallelized AST on single cell level.
Technology:
Microorganisms:
Application:
Development stage:
- Antimicrobial stewardship
- Microbial diagnostics
- Infection prevention
- Antimicrobial compound/strategy
- Removal antibiotics/bacteria
Microorganisms:
- Bacteria
- Viruses
- Fungi
- Yeasts
- Parasites
Application:
- Human
- Veterinary
- AgriFood
- Environmental
- Other
Development stage:
- Development
- Research
- Validation
- Market entry
- Marketed product
Organization:
Partnering:
Funding organisation:
Infectious disease area:
Geographic origin:
- Academia
- Company
- Institute
- NGO
- Government
Partnering:
- License
- Co-develop
- Outsource
- Joint Venture
- Sell
Funding organisation:
- OTHER / NA
- CARB-X
- FIND
- GARDP
- REPAIR
Infectious disease area:
- UTI
- BSI
- RTI
- GII
- CNSI
- IAI
- SSI
- STI
- SSTI
Geographic origin:
- Eurasia
- North America
- South America
- Africa
- Oceania
Looking for partners that can help validate and build our technology and business.
Graphiti is a pre start-up initiative aiming to bring fast (<1h) phenotypic Antimicrobial Susceptibility testing
Able to provide research services to (academic) hospitals, pharma discovery projects and diagnostic centers.